• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(Bonati)提取物和分离化合物的潜在抗糖尿病活性。

Potential Antidiabetic Activity of Extracts and Isolated Compound from (Bonati).

机构信息

CirTech Institute, HCMC University of Technology (HUTECH), Ho Chi Minh City 700000, Vietnam.

Institute of Applied Science, HCMC University of Technology (HUTECH), Ho Chi Minh City 700000, Vietnam.

出版信息

Biomolecules. 2020 Jan 29;10(2):201. doi: 10.3390/biom10020201.

DOI:10.3390/biom10020201
PMID:32013271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7072461/
Abstract

Bonati. () has been used in traditional and modern medicine in Vietnam for curing hepatitis. In this study, ethanol and aqueous extracts of were evaluated for their α-glucosidase inhibitory activities and anti-hyperglycemic effects on glucose loaded hyperglycemic and streptozotocin (STZ) induced diabetic mice. The α-glucosidase inhibition of the extracts was evaluated by colorimetric assays, and the anti-diabetic activity was tested on a STZ-induced diabetic mice model. The ethanol and aqueous extracts showed a significant α-glucosidase inhibitory activity, which was more effective than acarbose at the same concentration. In the STZ-induced diabetic mice, both extracts showed a strong anti-hyperglycemic activity, with the group receiving 50 mg/kg of ethanol extract and the group receiving 50 mg/kg of aqueous extract presenting 64.42% and 57.69% reductions, respectively, in the blood glucose levels when compared with the diabetic control group, on day 21 (). Isoscutellarein-8-O-β-D-glucopyranoside (IG) was identified from the ethanol extract, which showed a strong inhibitory activity against α-glucosidase, with a ten times higher potency compared with the positive control acarbose. The anti-hyperglycemic effect of IG was effectively similar to the standard drug, glibenclamide, at the same dose of 10 mg/kg (). These results indicated that has a great antidiabetic potential.

摘要

Bonati. () 在越南传统医学和现代医学中被用于治疗肝炎。在这项研究中,评估了 的乙醇和水提取物对α-葡萄糖苷酶的抑制活性以及对葡萄糖负荷性高血糖和链脲佐菌素 (STZ) 诱导的糖尿病小鼠的抗高血糖作用。通过比色法评估提取物的α-葡萄糖苷酶抑制作用,并在 STZ 诱导的糖尿病小鼠模型上测试抗糖尿病活性。乙醇和水提取物显示出显著的α-葡萄糖苷酶抑制活性,其在相同浓度下比阿卡波糖更有效。在 STZ 诱导的糖尿病小鼠中,两种提取物均表现出很强的抗高血糖活性,接受 50mg/kg 乙醇提取物的组和接受 50mg/kg 水提取物的组的血糖水平分别降低了 64.42%和 57.69%,与糖尿病对照组相比,在第 21 天 ()。从乙醇提取物中鉴定出了山柰素-8-O-β-D-吡喃葡萄糖苷 (IG),其对α-葡萄糖苷酶表现出强烈的抑制活性,其效力比阳性对照阿卡波糖高 10 倍。IG 的抗高血糖作用与标准药物格列本脲在相同剂量 10mg/kg 时的作用有效相似 ()。这些结果表明,Bonati. 具有很大的抗糖尿病潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a48/7072461/7467dbbfb0df/biomolecules-10-00201-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a48/7072461/d1834fe12b69/biomolecules-10-00201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a48/7072461/1f225e2c47ca/biomolecules-10-00201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a48/7072461/7467dbbfb0df/biomolecules-10-00201-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a48/7072461/d1834fe12b69/biomolecules-10-00201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a48/7072461/1f225e2c47ca/biomolecules-10-00201-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a48/7072461/7467dbbfb0df/biomolecules-10-00201-g003.jpg

相似文献

1
Potential Antidiabetic Activity of Extracts and Isolated Compound from (Bonati).(Bonati)提取物和分离化合物的潜在抗糖尿病活性。
Biomolecules. 2020 Jan 29;10(2):201. doi: 10.3390/biom10020201.
2
Evaluation of Antidiabetic Properties of Adenosma Bracteosum Bonati Extracts in Mice with Streptozotocin-Induced Diabetes.评价斑地锦提取物对链脲佐菌素诱导糖尿病小鼠的降血糖作用。
Methods Mol Biol. 2022;2343:165-178. doi: 10.1007/978-1-0716-1558-4_10.
3
Leaf Extract Reverses Alloxan/Nicotinamide-Induced Diabetes Mellitus in Rats through Hormonal (Insulin, GLP-1, and Glucagon) and Enzymatic (-Amylase/-Glucosidase) Modulation.叶提取物通过激素(胰岛素、GLP-1 和胰高血糖素)和酶(α-淀粉酶/α-葡萄糖苷酶)调节逆转链脲佐菌素/烟酰胺诱导的糖尿病大鼠模型。
Biomed Res Int. 2021 Jul 23;2021:9920826. doi: 10.1155/2021/9920826. eCollection 2021.
4
Antioxidant, α-glucosidase inhibitory activity and sub-chronic toxicity of Derris reticulata extract: its antidiabetic potential.鱼藤提取物的抗氧化、α-葡萄糖苷酶抑制活性及亚慢性毒性:其抗糖尿病潜力
BMC Complement Altern Med. 2015 Feb 27;15:35. doi: 10.1186/s12906-015-0552-4.
5
Hypoglycemic effects of aqueous persimmon leaf extract in a murine model of diabetes.柿叶水提取物对糖尿病小鼠模型的降血糖作用
Mol Med Rep. 2015 Aug;12(2):2547-54. doi: 10.3892/mmr.2015.3766. Epub 2015 May 8.
6
Curative Effect of Catechin Isolated from Thunb. Berries for Diabetes and Related Complications in Streptozotocin-Induced Diabetic Rats Model.杨梅叶多酚对链脲佐菌素诱导糖尿病大鼠模型糖尿病及相关并发症的疗效。
Molecules. 2020 Dec 30;26(1):137. doi: 10.3390/molecules26010137.
7
Hypoglycemic, hypolipidemic and antioxidant effects of Sarcandra glabra polysaccharide in type 2 diabetic mice.肿节风多糖对2型糖尿病小鼠的降血糖、降血脂及抗氧化作用
Food Funct. 2014 Nov;5(11):2850-60. doi: 10.1039/c4fo00430b.
8
Phytochemical analysis and antidiabetic potential of Elaeagnus umbellata (Thunb.) in streptozotocin-induced diabetic rats: pharmacological and computational approach.沙枣(Elaeagnus umbellata(Thunb.))的植物化学分析及在链脲佐菌素诱导的糖尿病大鼠中的抗糖尿病潜力:药理学和计算方法。
BMC Complement Altern Med. 2018 Dec 13;18(1):332. doi: 10.1186/s12906-018-2381-8.
9
Antidiabetic activity, glucose uptake stimulation and α-glucosidase inhibitory effect of Chrysophyllum cainito L. stem bark extract.鸡蛋果茎皮提取物的降血糖活性、葡萄糖摄取刺激作用和α-葡萄糖苷酶抑制作用。
BMC Complement Altern Med. 2018 Oct 1;18(1):267. doi: 10.1186/s12906-018-2328-0.
10
Antidiabetic activities of Tecoma stans (L.) Juss. ex Kunth.黄钟花的抗糖尿病活性
J Ethnopharmacol. 2009 Jul 15;124(2):284-8. doi: 10.1016/j.jep.2009.04.033. Epub 2009 May 3.

引用本文的文献

1
Evaluating the Antidiabetic Activity of Latex in Alloxan-Induced Diabetic Rats and the Development of a Novel Effervescent Granule-Based Delivery System.评估乳胶对四氧嘧啶诱导的糖尿病大鼠的抗糖尿病活性以及开发一种基于泡腾颗粒的新型给药系统。
ScientificWorldJournal. 2025 Jan 9;2025:5648662. doi: 10.1155/tswj/5648662. eCollection 2025.
2
Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer's Disease.脑胰岛素抵抗介导的认知障碍和神经退行性变:3型糖尿病还是阿尔茨海默病。
Acta Neurol Belg. 2025 Jan 7. doi: 10.1007/s13760-024-02706-7.
3
Isolation and Characterization of Novel Pueroside B Isomers and Other Bioactive Compounds from Roots: Structure Elucidation, -Glucosidase, and -Amylase Inhibition Studies.

本文引用的文献

1
Preclinical and clinical results regarding the effects of a plant-based antidiabetic formulation versus well established antidiabetic molecules.植物源抗糖尿病配方与已确立的抗糖尿病分子的临床前和临床效果。
Pharmacol Res. 2019 Dec;150:104522. doi: 10.1016/j.phrs.2019.104522. Epub 2019 Nov 4.
2
Understanding glycaemic control and current approaches for screening antidiabetic natural products from evidence-based medicinal plants.了解血糖控制以及从循证药用植物中筛选抗糖尿病天然产物的当前方法。
Plant Methods. 2019 Sep 7;15:105. doi: 10.1186/s13007-019-0487-8. eCollection 2019.
3
Trends in incidence of total or type 2 diabetes: systematic review.
从根部分离鉴定新型槐糖苷 B 异构体和其他生物活性化合物:结构阐明、-葡萄糖苷酶和 -淀粉酶抑制研究。
Int J Mol Sci. 2024 Sep 4;25(17):9602. doi: 10.3390/ijms25179602.
4
Potential use of (V. Tiegh.) Lec. extract for the treatment of diabetes.(V. Tiegh.) Lec. 提取物在治疗糖尿病方面的潜在用途。
Indian J Pharmacol. 2023 Jul-Aug;55(4):237-242. doi: 10.4103/ijp.ijp_253_23.
5
Recent Updates on Phytoconstituent Alpha-Glucosidase Inhibitors: An Approach towards the Treatment of Type Two Diabetes.植物成分α-葡萄糖苷酶抑制剂的最新进展:一种治疗2型糖尿病的方法
Plants (Basel). 2022 Oct 14;11(20):2722. doi: 10.3390/plants11202722.
6
A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes.植物来源的α-葡萄糖苷酶抑制剂作为2型糖尿病潜在治疗药物的综述。
Phytochem Rev. 2022;21(4):1049-1079. doi: 10.1007/s11101-021-09773-1. Epub 2021 Aug 16.
7
Are Ancestral Medical Practices the Future Solution to Today's Medical Problems?祖传医学实践是否是当今医疗问题的未来解决方案?
Molecules. 2021 Aug 3;26(15):4701. doi: 10.3390/molecules26154701.
8
Topical Collection "Pharmacology of Medicinal Plants".专题集:药用植物的药理学。
Biomolecules. 2021 Jan 14;11(1):101. doi: 10.3390/biom11010101.
9
Anti-Hepatocellular-Cancer Activity Exerted by β-Sitosterol and β-Sitosterol-Glucoside from Miq.米槁中β-谷甾醇和β-谷甾醇葡萄糖苷的抗肝癌活性
Molecules. 2020 Jul 2;25(13):3021. doi: 10.3390/molecules25133021.
10
Anticancer Activity of Novel Plant Extracts and Compounds from (Bonati) in Human Lung and Liver Cancer Cells.新型植物提取物及(Bonati)化合物在人肺癌和肝癌细胞中的抗癌活性。
Molecules. 2020 Jun 24;25(12):2912. doi: 10.3390/molecules25122912.
糖尿病发病率的趋势:系统综述。
BMJ. 2019 Sep 11;366:l5003. doi: 10.1136/bmj.l5003.
4
Relationship Between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues.2型糖尿病中氧化应激、内质网应激与炎症之间的关系:战斗仍在继续。
J Clin Med. 2019 Sep 4;8(9):1385. doi: 10.3390/jcm8091385.
5
Genetic Factors of Cerebral Small Vessel Disease and Their Potential Clinical Outcome.脑小血管病的遗传因素及其潜在临床转归。
Int J Mol Sci. 2019 Sep 3;20(17):4298. doi: 10.3390/ijms20174298.
6
Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment.用于轻度认知障碍诊断的潜在体液生物标志物。
Int J Mol Sci. 2019 Aug 25;20(17):4149. doi: 10.3390/ijms20174149.
7
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus.理解二甲双胍在 2 型糖尿病中的糖调节机制。
Nat Rev Endocrinol. 2019 Oct;15(10):569-589. doi: 10.1038/s41574-019-0242-2. Epub 2019 Aug 22.
8
Recent advances in the treatment of using biotherapeutic agents.使用生物治疗药物进行治疗的最新进展。 (原句“Recent advances in the treatment of using biotherapeutic agents.”表述不完整,推测完整句子可能是“Recent advances in the treatment of [某种疾病等] using biotherapeutic agents.” 这里按现有内容翻译)
Infect Drug Resist. 2019 Jun 10;12:1597-1615. doi: 10.2147/IDR.S207572. eCollection 2019.
9
Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles.使用抗生素和纳米药物递送载体治疗致病性感染的最新进展。
Drug Des Devel Ther. 2019 Jan 18;13:327-343. doi: 10.2147/DDDT.S190577. eCollection 2019.
10
Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer's Disease.肠道微生物群及其在阿尔茨海默病中的神经炎症意义。
Nutrients. 2018 Nov 14;10(11):1765. doi: 10.3390/nu10111765.